106 filings
Page 2 of 6
8-K
7n59s
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm
8-K
j7b0ya91
17 Oct 23
Talaris Therapeutics Announces Stockholder Approval of Merger with Tourmaline Bio
6:35pm
425
ici575
10 Oct 23
Business combination disclosure
4:32pm
8-K/A
kua vv1kj2la
10 Oct 23
Other Events
4:30pm
425
qnkx810wx
10 Oct 23
Business combination disclosure
12:00am
8-K
9bbvn oxw9
6 Oct 23
Talaris Therapeutics Declares Special Dividend
5:30pm
425
k8pnlhkkf6vug2nwglf
6 Oct 23
Business combination disclosure
5:27pm
8-K
fupsft0df 61oclz
6 Oct 23
Other Events
5:26pm
425
ovxe96x2
26 Sep 23
Business combination disclosure
8:24am
8-K
z99fba 2g
26 Sep 23
Regulation FD Disclosure
8:21am
424B3
qgrphj5jqocmfmcrm6a
15 Sep 23
Prospectus supplement
6:31am
EFFECT
0shb6n 0c9bj8fo
15 Sep 23
Notice of effectiveness
12:15am
SEC STAFF LETTER
r0semo5b rj
14 Sep 23
SEC staff letter
12:00am
425
hn2tr0 4u8v9osmr9g9
13 Sep 23
Business combination disclosure
9:14am
8-K
pxoyerxy7jtaaumlymp
13 Sep 23
Regulation FD Disclosure
9:13am
CORRESP
a8ux4li2fe ixutd8b
13 Sep 23
Correspondence with SEC
12:00am
CORRESP
3j5ol4t74cs 9msh9e7p
11 Sep 23
Correspondence with SEC
12:00am
UPLOAD
fcxr27q2qtffk8do
6 Sep 23
Letter from SEC
12:00am